The Responsible Person (RP) plays a critical role in the UK medical cannabis industry, ensuring compliance with Good Distribution Practice (GDP) and Medicines and Healthcare products Regulatory Agency (MHRA) regulations. If you are looking to become an RP in this...
Medicexum Blog | UK Medical Cannabis News & Insights
How Media Bias is Holding Back the Cannabis Industry
The medicinal cannabis industry has made significant strides in recent years, with growing acceptance from medical professionals, regulators, and consumers. However, despite scientific advancements and evolving legislation, public perception remains a major hurdle....
The Importance of MHRA Compliance for UK Medical Cannabis Brands
In recent years, the UK’s medical cannabis industry has seen rapid growth, with increasing numbers of patients seeking prescriptions for a variety of health conditions. However, with this expansion comes increased scrutiny from regulators, the media, and the general...
UK Medical Cannabis Stability Testing: ICH Guidelines & Compliance
Medical cannabis stability studies are a crucial aspect of ensuring product safety, efficacy, and compliance with UK, European, and international regulatory frameworks. In the UK, stability testing must adhere to ICH guidelines, as well as the British Pharmacopoeia...
Why Now is the Best Time to Invest in the UK Medical Cannabis Market
The UK medical cannabis industry is experiencing rapid growth, driven by regulatory advancements, increasing patient demand, and expanding investment opportunities. With the UK government taking steps to create a structured framework for medical cannabis, now is the...
The Global Cannabis Market 2024: Key Insights & Trends
The global cannabis industry is experiencing dynamic changes in legalisation, market expansion, and medical cannabis accessibility. Businesses and investors must stay informed about policy shifts, emerging markets, and growth opportunities. At Medicexum, we provide...